Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option

The treatment of metastatic melanoma patients with autologous tumor-infiltrating lymphocytes (TIL) shows robust, reproducible, clinical responses in clinical trials executed in several specialized centers over the world. Even in the era of targeted therapy and immune checkpoint inhibition, TIL thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Rohaan, Maartje W., van den Berg, Joost H., Kvistborg, Pia, Haanen, John B. A. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171186/
https://www.ncbi.nlm.nih.gov/pubmed/30285902
http://dx.doi.org/10.1186/s40425-018-0391-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171186/
https://www.ncbi.nlm.nih.gov/pubmed/30285902
http://dx.doi.org/10.1186/s40425-018-0391-1

Ejemplares similares